Explore more publications!

Press Releases

Swiss L1 QoreChain Pulls Mainnet Forward to Q2 2026, Ships NIST-Standard Post-Quantum Cryptography in Production
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
Chinese Top 3 Car Radio Manufacturers in 2026: Pioneering Global Automotive Infotainment Innovation
Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
SUSE Honors Global Innovators with 2026 Customer Awards at SUSECON Prague
The Medical Affairs Professional Society (MAPS) Announces Presenters for their 2026 EMEA Annual Meeting in Zurich
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
Switzerland Moves to Tighten Restrictions on Foreign Property Buys

Switzerland Moves to Tighten Restrictions on Foreign Property Buys

Sikhs in Clinical Research Highlights Community Engagement Efforts to Improve Health and Research Literacy
CE’s first four-nation visit aiming to showcase success of ‘One country, two systems’ and expand pragmatic cooperation

CE’s first four-nation visit aiming to showcase success of ‘One country, two systems’ and expand pragmatic cooperation

Leading science competition announces 25 international pioneers who can help humanity live within Earth’s boundaries
Sportradar to Release First Quarter 2026 Financial and Operating Results on May 6, 2026
CE to visit Portugal, Spain, Switzerland, and Belgium

CE to visit Portugal, Spain, Switzerland, and Belgium

Oculis Publishes Invitation to the Annual General Meeting
FX Junction Among the Top 3 Social Trading Platforms in Industry Review
AMP Ahead: HMP Global’s AMP 2026 Advances the Future of CLTI Innovation and Education
WeRide and GAC Debut First Co-Developed Vehicle Aion N60 Powered by WRD 3.0
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
Monolithic Power Systems to Report First Quarter 2026 Results on April 30, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions